US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist

14.780
+0.580+4.08%

Close Mar 28 16:00 ET

14.780
0.0000.00%

Post 20:01 ET

2.15BMarket Cap-5.75P/E (TTM)

Denali Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Denali Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 7.786M	--
--	2025/Q1	-- / 3.241M	--
--	2024/Q4	0.000 / 12.753M	--
--	2024/Q3	0.000 / 8.357M	--
--	2024/Q2	0.000 / 10.773M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 7.786M--

--2025/Q1-- / 3.241M--

--2024/Q40.000 / 12.753M--

--2024/Q30.000 / 8.357M--

--2024/Q20.000 / 10.773M--

Unlock Free Earnings Estimates

Open Account

Denali Therapeutics Earnings Reports

Denali Therapeutics | 8-K: Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Feb 27 16:13 ET

Denali Therapeutics | 10-K: FY2024 Annual Report

Feb 27 16:06 ET

Denali Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:22 ET

Denali Therapeutics | 8-K: Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 6, 2024 16:21 ET